# AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

> **NCT06699056** · — · RECRUITING · sponsor: **Peerbridge Health, Inc** · enrollment: 1500 (estimated)

## Conditions studied

- Ventricular Ejection Fraction
- LVF
- LV Dysfunction
- Atrial Enlargement
- Conduction Defect
- Heart Failure
- Valvular Heart Disease
- Ischemic Heart Disease
- Cardiotoxicity
- Myocardial Infarction
- Dilated Cardiomyopathy
- HFrEF - Heart Failure With Reduced Ejection Fraction
- HFpEF - Heart Failure With Preserved Ejection Fraction
- Syncope
- Remodeling, Cardiac

## Interventions

- **DEVICE:** 15-minutes of sitting during COR ECG Acquistion

## Key facts

- **NCT ID:** NCT06699056
- **Lead sponsor:** Peerbridge Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-21
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699056, "AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06699056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*